Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Iwata

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 28, 2018
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of <sup>1</sup>H-MRS studiesYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 30, 2021
Reliability and Validity of the Japanese Version of the Barthel Index Dyspnea Among Patients with Respiratory DiseasesTakumi Yamaguchi, Akio Yamamoto, Yutaro Oki, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 3, 2018
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) dataMiracle Ozzoude, Shinichiro Nakajima, Eric Plitman, et al.
Schizophrenia Bulletin|February 11, 2017
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysisEric Plitman, Yusuke Iwata, Fernando Caravaggio, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 26, 2024
Neuronal viability/astrocyte activity ratio in the dorsolateral prefrontal cortex as a biomarker of Alzheimer's dementia: a proton magnetic resonance spectroscopy studyShreya Jha, Edgardo Torres-Carmona, Yusuke Iwata, et al.
Diabetes & Metabolic Syndrome|March 8, 2020
DAS: The Diabetes Awareness and Insight ScaleJulia Kim, Parita Shah, Lena C Quilty, et al.
Medical Hypotheses|February 27, 2017
Impaired illness awareness and leftward visuospatial inattention in schizophrenia are attributable to a common neural deficit - Posterior parietal hemispheric imbalanceJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
Human Brain Mapping|July 29, 2017
The relationship between subcortical brain volume and striatal dopamine D<sub>2/3</sub> receptor availability in healthy humans assessed with [<sup>11</sup> C]-raclopride and [<sup>11</sup> C]-(+)-PHNO PETFernando Caravaggio, Jun Ku Chung, Eric Plitman, et al.
Schizophrenia Research|January 4, 2015
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E dataShinichiro Nakajima, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Journal of Alzheimer'S Disease : JAD|November 1, 2015
Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 28, 2018
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of <sup>1</sup>H-MRS studiesYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 30, 2021
Reliability and Validity of the Japanese Version of the Barthel Index Dyspnea Among Patients with Respiratory DiseasesTakumi Yamaguchi, Akio Yamamoto, Yutaro Oki, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 3, 2018
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) dataMiracle Ozzoude, Shinichiro Nakajima, Eric Plitman, et al.
Schizophrenia Bulletin|February 11, 2017
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysisEric Plitman, Yusuke Iwata, Fernando Caravaggio, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 26, 2024
Neuronal viability/astrocyte activity ratio in the dorsolateral prefrontal cortex as a biomarker of Alzheimer's dementia: a proton magnetic resonance spectroscopy studyShreya Jha, Edgardo Torres-Carmona, Yusuke Iwata, et al.
Diabetes & Metabolic Syndrome|March 8, 2020
DAS: The Diabetes Awareness and Insight ScaleJulia Kim, Parita Shah, Lena C Quilty, et al.
Medical Hypotheses|February 27, 2017
Impaired illness awareness and leftward visuospatial inattention in schizophrenia are attributable to a common neural deficit - Posterior parietal hemispheric imbalanceJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
Human Brain Mapping|July 29, 2017
The relationship between subcortical brain volume and striatal dopamine D<sub>2/3</sub> receptor availability in healthy humans assessed with [<sup>11</sup> C]-raclopride and [<sup>11</sup> C]-(+)-PHNO PETFernando Caravaggio, Jun Ku Chung, Eric Plitman, et al.
Schizophrenia Research|January 4, 2015
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E dataShinichiro Nakajima, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Journal of Alzheimer'S Disease : JAD|November 1, 2015
Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Pageof 12